Research

Topics Publications In progress publications Communications

Packages

AnaQol Project PRO-online R Packages Online R-package

Life of the unit

Projects Collaborations PhD thesis Traineeships Traineeships propositions Seminars

Next seminars

18 octobre 2018 Bastien Perrot Le dépistage du jeu problématique

30 novembre 2018 Julien Nizard et Adrien Evin Evaluation et de prise en charge de la qualité de vie dans le domaine de la Douleur, des Soins Palliatifs et des soins de support

Last publications

03 novembre 2018 Sauvaget A, Jiménez-Murcia S, Fernández-Aranda F, Granero R, Grall-Bronnec M, Victorri-Vigneau C, Bulteau S, Derkinderen P, Vanelle J, Hakansson A, Mestre-Bach G, Steward T, Menchón JM (2018) A Comparison of Treatment-Seeking Behavioral Addiction Patients with and without Parkinson's Disease. Front Psychiatry, 8: 214.

17 septembre 2018 Perrot B, Hardouin JB, Grall-Bronnec M, Challet G (2018) Typology of online lotteries and scratch games gamblers’ behaviours: a multilevel latent class cluster analysis applied to player account-based gambling data. International Journal of Methods in Psychiatric Research: .

15 août 2018 Quénéhervé L, David G, Bourreille , Hardouin JB, Rahmi G, Neunlist M, Brégeon J, Coron E (2018) Quantitative assessment of mucosal architecture using computer-based analysis of confocal laser endomicroscopy in inflammatory bowel diseases. Gastrointestinal Endoscopy: under press.

27 juillet 2018 Couvrat-Desvergnes G, Foucher Y, Le Borgne F, Dion A, Mourad G, Garrigue V, Legendre C, Rostaing L, Kamar N, Kessler M, Ladrière M, Morelon E, Buron F, Giral M, Dantan E (2018) Comparison of graft and patient survival according to the transplantation centre policy for 1-year screening biopsy among stable kidney recipients: a propensity score-based study. Nephrol Dial Transplant: .

27 juillet 2018 Bulteau S, Grall-Bronnec M, Bars P, Laforgue E, Etcheverrigaray F, Loirat J, Victorri-Vigneau C, Vanelle J, Sauvaget A (2018) Bipolar disorder and adherence: implications of manic subjective experience on treatment disruption. Patient Prefer Adherence, 12: 1355-1361.

Updated

11 octobre 2018

Annie-Pierre Jonville-Bera

Situation

Poste : PH Pharmacologie
Institution : CHU de Tours

Publications scientifiques

Articles dans une revue internationale

1. Cornillier H, Giraudeau B, Munck S, Hacard F, Jonville-Bera AP, d'Acremont G, Pham B, Maruani A (2018) Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol: Epub ahead of print.
2. Bailly E, Von Tokarski F, Beau-Salinas F, Picon L, Miquelestorena-Standley E, Rousseau G, Jonville-Bera AP, Halimi JM (2018) Interstitial Nephritis Secondary to Vedolizumab Treatment in Crohn Disease and Safe Rechallenge Using Steroids: A Case Report. Am J Kidney Dis, 71(1): 142-5.
3. Bouquet E, Jourdain M, Machet M, Beau-Salinas F, Jonville-Bera AP (2017) Dasatinib-associated follicular lymphoid hyperplasia: First pediatric case report and literature review. Pediatr Blood Cancer, 64(11): doi: 10.1002/pbc.26597. Epub 2017 Apr 25.
4. Le Moigne M, Bulteau S, Grall-Bronnec M, Gerardin M, Fournier J, Jonville-Bera AP, Jolliet P, Dreno B, Victorri-Vigneau C (2017) Psychiatric disorders, acne and systemic retinoids: comparison of risks. Expert Opin Drug Saf, 16(9): 989-95.
5. Cornillier H, Kervarrec T, Tabareau-Delalande F, Mammou S, Jonville-Bera AP, Machet L (2016) Interstitial granulomatous dermatitis occurring in a patient with SAPHO syndrome one month after starting leflunomide, and subsequently disappearing with ustekinumab. Eur J Dermatol, 26(6): 614-5.
6. Agier MS, Boivin N, Maruani A, Giraudeau B, Gouraud A, Haramburu F, Jean-Pastor M, Machet L, Jonville-Bera AP (2016) Risk assessment of drug-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome: a disproportionality analysis using the French Pharmacovigilance Database. Br J Dermatol, 175(5): 1067-9.
7. Kaguelidou F, Beau-Salinas F, Jonville-Bera AP, Jacqz-Aigrain E (2016) Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database. Br J Clin Pharmacol, 82(4): 1058-68.
8. Winterfeld U, Merlob P, Baud D, Rousson V, Panchaud A, Rothuizen L, Bernard N, Vial T, Yates L, Pistelli A, Ellfolk M, Eleftheriou G, de Vries L, Jonville-Bera AP, Kadioglu M, Biollaz J, Buclin T (2016) Pregnancy outcome following maternal exposure to pregabalin may call for concern. Neurology, 86(24): 2251-7.
9. Nadal M, Giraudeau B, Tavernier E, Jonville-Bera AP, Lorette G, Maruani A (2016) Efficacy and Safety of Mammalian Target of Rapamycin Inhibitors in Vascular Anomalies: A Systematic Review. Acta Derm Venereol, 96(4): 448-52.
10. Marret H, Simon E, Beucher G, Dreyfus M, Gaudineau A, Vayssière C, Lesavre M, Pluchon M, Winer N, Fernandez H, Aubert J, Bejan-Angoulvan T, Jonville-Bera AP, Clouqueur E, Houfflin-Debarge V, Garrigue A, Pierre F, Collège National des Gynécologues Obstétriciens Français (2015) Overview and expert assessment of off-label use of misoprostol in obstetrics and gynaecology: review and report by the Collège national des gynécologues obstétriciens français. Eur J Obstet Gynecol Reprod Biol, 187: 80-4.

Chapitres d'ouvrage

1. Damase-Michel C, Jean-Pastor M, Jolliet P, Jonville-Bera AP, Lacroix I, Louvigne C, Parry E (2012) Chapitre 15 – Infectiologie : 15.1 Antibiotiques. . In « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.
2. Louvigne C, Jolliet P, Jonville-Bera AP (2012) Chapitre 20 – Pneumologie. In Participation à un livre : « Médicaments et grossesse : prescrire et évaluer le risque » Annie-Pierre Jonville-Béra, Thierry Vial Edition Elsevier Masson (): 0.

Articles dans une revue nationale

1. Simon C, Lengellé C, Agier MS, Beau-Salinas F, Vrignaud L, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(11): 1150-7.
2. Alami Z, Agier MS, Ahid S, Vial T, Dautriche A, Lagarce L, Toutain A, Cherrah Y, Jonville-Bera AP (2017) Pregnancy outcome following in utero exposure to azathioprine: A French comparative observational study. Therapie: pii: S0040-5957(17)30152-X. doi: 10.1016/j.therap.2017.06.006. [Epub ahead of print].
3. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(9): 906-7.
4. Vrignaud L, Simon C, Agier MS, Bejan-Angoulvant T, Bouquet E, Beau-Salinas F, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(8): 783-7.
5. Beau-Salinas F, Bouquet E, Vrignaud L, Simon C, Agier MS, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(5): 501-6.
6. Agier MS, Marchand S, Paret N, Gautier S, Jonville-Bera AP (2017) [Post-licensure safety surveillance for Prevenar 13® in France]. Arch Pediatr, 24(5): 439-44.
7. Weber E, Moulis G, Mahévas M, Guy C, Lioger B, Durieu I, Hunault M, Ramanantsoa M, Royer B, Default A, Perault-Pochat M, Moachon L, Bernard N, Bardy G, Jonville-Bera AP, Geniaux H, Godeau B, Cathébras P (2017) [Thrombosis during thrombopoietin receptor agonist treatment for immune thrombocytopenia. A French multicentric observational study]. Rev Med Interne, 38(3): 167-75.
8. Agier MS, Beau-Salinas F, Bejan-Angoulvant T, Lengellé C, Jonville-Bera AP (2017) [Drugs news]. Arch Pediatr, 24(1): 81-6.
9. Agier MS, Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(11): 1204-16.
10. Simon C, Agier MS, Béné J, Muller C, Vrignaud L, Marret H, Jonville-Bera AP (2016) [Safety profile of etonogestrel contraceptive implant (Nexplanon® and Implanon®) reported in France]. J Gynecol Obstet Biol Reprod, 45(9): 1074-82.
11. Agier MS, Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(9): 1002-5.
12. Jonville-Bera AP, Mallaret M, Sgro C, Association Française des Centres Régionaux de Pharmacovigilance (2016) [The congress of the French Society of Pharmacology and Therapeutics celebrate in Nancy, 20 April 2016, 40 years of French Regional Pharmacovigilance Centres!]. Thérapie, 71(4): 351-4.
13. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Agier MS, Jonville-Bera AP (2016) [Drugs news]. Arch Pediatr, 23(6): 646-52.
14. Jonville-Bera AP, Vial T, Sgro C, Mallaret M, Association Française des Centres Régionaux de Pharmacovigilance (2016) [On the absence of reimbursement of rotavirus vaccine in France]. Arch Pediatr, 23(6): 655-7.
15. Lengellé C, Bejan-Angoulvant T, Beau-Salinas F, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(11): 1200-6.
16. Maruani A, Carriot M, Jonville-Bera AP, Lorette G, Gissot V, association Recommandations en Dermatologie (aRED) (2015) [Highlight on clinical research in pediatrics]. Ann Dermatol Venereol, 142(6): 446-9.
17. Bejan-Angoulvant T, Crochet J, Jonville-Bera AP (2015) [Calcium channel blockers pharmacology and their use as tocolytics]. J Gynecol Obstet Biol Reprod, 44(4): 305-11.
18. Beau-Salinas F, Lengellé C, Bejan-Angoulvant T, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(4): 440-6.
19. Bejan-Angoulvant T, Beau-Salinas F, Lengellé C, Cissoko H, Jonville-Bera AP (2015) [Drugs news]. Arch Pediatr, 22(2): .

Communications scientifiques

Poster dans un colloque national (idpers=1398)

1. Picard S., Leven C., Jonville-Bera A.P., Riche C., Perault-Pochat M., Lainé-Cessac P., Coquerel A., Jolliet P., Renaudineau E. Etude prospective sur les néphropathies immunoallergiques (NIA) médicamenteuses dans 11 unités françaises de néphrologie.9ème Congrès de Physiologie de Pharmacologie et de thérapeutique, Poitiers, 22-24 avril 2014, 2014.